Feedback / Questions
vobarilizumab (ALX-0061) - Sanofi
Ablynx: J.P. Morgan Healthcare Conference
(Ablynx)
-
Jan 11, 2013 -
Anticipated patent expiry including extensions in 2032/2033
Anticipated patent expiry
•
Immunology • Rheumatoid Arthritis
http://www.larvolonline.com/tlg/ccdb/AblynxJPMorganHealthcareConferenceJan102013.PDF
Jan 11, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.